FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800603965> ?p ?o ?g. }

• W2800603965 abstract "Abstract Sodium glucose cotransporter 2 (SGLT2) inhibitors, an antidiabetic drug, promotes urinary excretion of glucose by blocking its reabsorption in the renal proximal tubules. It is unclear whether SGLT2 inhibition could attenuate nonalcoholic steatohepatitis (NASH) and NASH-associated hepatocellular carcinoma. We examined the preventive effects of an SGLT2 inhibitor canagliflozin (CANA) in Western diet (WD)-fed melanocortin 4 receptor-deficient (MC4R-KO) mice, a mouse model of human NASH. An eight-week CANA treatment attenuated hepatic steatosis in WD-fed MC4R-KO mice, with increased epididymal fat mass without inflammatory changes. CANA treatment for 20 weeks inhibited the development of hepatic fibrosis in WD-fed MC4R-KO mice. After one year of CANA treatment, the number of liver tumors was significantly reduced in WD-fed MC4R-KO mice. In adipose tissue, CANA suppressed the ratio of oxidative to reduced forms of glutathiones (GSSG/GSH) in WD-fed MC4R-KO mice. Treatment with GSH significantly attenuated the H 2 O 2 -induced upregulation of genes related to NADPH oxidase in 3T3-L1 adipocytes, and that of Il6 , Tgfb , and Pdgfb in RAW264.7 cells. This study provides evidence that SGLT2 inhibitors represent the unique class of drugs that can attenuate or delay the onset of NASH and eventually hepatocellular carcinoma, at least partly, through “healthy adipose expansion”." @default.
• W2800603965 created "2018-05-17" @default.
• W2800603965 creator A5002748194 @default.
• W2800603965 creator A5003848347 @default.
• W2800603965 creator A5016218854 @default.
• W2800603965 creator A5016471389 @default.
• W2800603965 creator A5024122797 @default.
• W2800603965 creator A5039655548 @default.
• W2800603965 creator A5047939923 @default.
• W2800603965 creator A5048106257 @default.
• W2800603965 creator A5071467213 @default.
• W2800603965 creator A5074060371 @default.
• W2800603965 creator A5075093137 @default.
• W2800603965 creator A5089963919 @default.
• W2800603965 date "2018-02-05" @default.
• W2800603965 modified "2023-10-17" @default.
• W2800603965 title "Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH" @default.
• W2800603965 cites W1170639820 @default.
• W2800603965 cites W1514549686 @default.
• W2800603965 cites W1818618752 @default.
• W2800603965 cites W1856151485 @default.
• W2800603965 cites W1882608036 @default.
• W2800603965 cites W1891967301 @default.
• W2800603965 cites W1943654307 @default.
• W2800603965 cites W1981456793 @default.
• W2800603965 cites W1983417944 @default.
• W2800603965 cites W2003764582 @default.
• W2800603965 cites W2006408441 @default.
• W2800603965 cites W2017849767 @default.
• W2800603965 cites W2021988691 @default.
• W2800603965 cites W2022419155 @default.
• W2800603965 cites W2029811522 @default.
• W2800603965 cites W2029827552 @default.
• W2800603965 cites W2035816889 @default.
• W2800603965 cites W2042363298 @default.
• W2800603965 cites W2052041349 @default.
• W2800603965 cites W2065612971 @default.
• W2800603965 cites W2068171948 @default.
• W2800603965 cites W2095574383 @default.
• W2800603965 cites W2103156933 @default.
• W2800603965 cites W2105196519 @default.
• W2800603965 cites W2106768039 @default.
• W2800603965 cites W2107887255 @default.
• W2800603965 cites W2122077393 @default.
• W2800603965 cites W2122860085 @default.
• W2800603965 cites W2124821727 @default.
• W2800603965 cites W2125668983 @default.
• W2800603965 cites W2126919962 @default.
• W2800603965 cites W2140978167 @default.
• W2800603965 cites W2141060229 @default.
• W2800603965 cites W2141189887 @default.
• W2800603965 cites W2142844314 @default.
• W2800603965 cites W2147972484 @default.
• W2800603965 cites W2157405334 @default.
• W2800603965 cites W2159229970 @default.
• W2800603965 cites W2159970068 @default.
• W2800603965 cites W2163691580 @default.
• W2800603965 cites W2166613497 @default.
• W2800603965 cites W2169786024 @default.
• W2800603965 cites W2174107467 @default.
• W2800603965 cites W2176471470 @default.
• W2800603965 cites W2189784675 @default.
• W2800603965 cites W2215535790 @default.
• W2800603965 cites W2217349032 @default.
• W2800603965 cites W2224883440 @default.
• W2800603965 cites W2302367542 @default.
• W2800603965 cites W2404306813 @default.
• W2800603965 cites W2415267894 @default.
• W2800603965 cites W2531626219 @default.
• W2800603965 cites W2604353718 @default.
• W2800603965 cites W2726939337 @default.
• W2800603965 cites W291108153 @default.
• W2800603965 doi "https://doi.org/10.1038/s41598-018-19658-7" @default.
• W2800603965 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5799179" @default.
• W2800603965 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29402900" @default.
• W2800603965 hasPublicationYear "2018" @default.
• W2800603965 type Work @default.
• W2800603965 sameAs 2800603965 @default.
• W2800603965 citedByCount "102" @default.
• W2800603965 countsByYear W28006039652018 @default.
• W2800603965 countsByYear W28006039652019 @default.
• W2800603965 countsByYear W28006039652020 @default.
• W2800603965 countsByYear W28006039652021 @default.
• W2800603965 countsByYear W28006039652022 @default.
• W2800603965 countsByYear W28006039652023 @default.
• W2800603965 crossrefType "journal-article" @default.
• W2800603965 hasAuthorship W2800603965A5002748194 @default.
• W2800603965 hasAuthorship W2800603965A5003848347 @default.
• W2800603965 hasAuthorship W2800603965A5016218854 @default.
• W2800603965 hasAuthorship W2800603965A5016471389 @default.
• W2800603965 hasAuthorship W2800603965A5024122797 @default.
• W2800603965 hasAuthorship W2800603965A5039655548 @default.
• W2800603965 hasAuthorship W2800603965A5047939923 @default.
• W2800603965 hasAuthorship W2800603965A5048106257 @default.
• W2800603965 hasAuthorship W2800603965A5071467213 @default.
• W2800603965 hasAuthorship W2800603965A5074060371 @default.
• W2800603965 hasAuthorship W2800603965A5075093137 @default.
• W2800603965 hasAuthorship W2800603965A5089963919 @default.
• W2800603965 hasBestOaLocation W28006039651 @default.
• W2800603965 hasConcept C126322002 @default.

• next